Loading…
Anixa Biosciences, Inc. is projected to rise to $3.75 by 2027, a +22% move from its current price of $3.06. ANIX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $2.95 | $3.06 | $3.18 | -0.03% |
| Jul 14 | $2.90 | $3.06 | $3.23 | -0.05% |
| Jul 15 | $2.86 | $3.06 | $3.26 | -0.08% |
| Jul 16 | $2.83 | $3.06 | $3.30 | -0.11% |
| Jul 17 | $2.81 | $3.06 | $3.33 | -0.13% |
| Jul 18 | $2.78 | $3.06 | $3.35 | -0.16% |
| Jul 19 | $2.76 | $3.05 | $3.38 | -0.19% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.76 | $3.05 | $3.38 | -0.19% |
| Week 2 | $2.65 | $3.05 | $3.51 | -0.38% |
| Week 3 | $2.56 | $3.04 | $3.62 | -0.56% |
| Week 4 | $2.49 | $3.04 | $3.71 | -0.75% |
| Week 5 | $2.42 | $3.03 | $3.79 | -0.94% |
| Week 6 | $2.37 | $3.03 | $3.87 | -1.13% |
| Week 7 | $2.32 | $3.02 | $3.94 | -1.31% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Anixa Biosciences, Inc. is a biotechnology company that develops therapies and vaccines focused on critical unmet needs in oncology. Its therapeutics programs include liraltagene autoleucel, a chimeric endocrine receptor-T cell therapy, a novel form of CAR-T technology that is focused on treating ovarian cancer.
The company is also engaged in developing a vaccine against breast cancer and a vaccine discovery program to develop additional cancer vaccines to address intractable cancers, including high incidence malignancies in lung, colon, and prostate. Anixa Biosciences, Inc. was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc.
in October 2018. It was incorporated in 1982 and is based in San Jose, California.
ANIX is currently priced at $3.14 per share, with a market cap of $106.83M and a rank of 4200 in market capitalization. The stock sits in the small-cap tier and is subject to notable price movement relative to its size. The technical picture shows bullish signals, with RSI at 70 and moving averages around key levels ($2.79 for the 50-day and $3.30 for the 200-day).
The stock trades between support of $2.35 and resistance of $3.14, with a 30-day price range of $2.46 to $4.01. Annualized volatility stands at 70%, highlighting sizable short-term price variability.
A major floor 35.5% below — a decisive break under it would weaken the trend.
The nearest floor, 23.2% below — buyers have tended to step in here.
The nearest ceiling, 6.9% above — a clean break opens room to run.
A major ceiling 24.6% above — clearing it would confirm fresh momentum.
Key ANIX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ANIX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.08 | Sell | $3.09 | Sell |
| MA 10 | $3.02 | Buy | $3.02 | Buy |
| MA 20 | $2.84 | Buy | $2.91 | Buy |
| MA 50 | $2.80 | Buy | $2.83 | Buy |
| MA 100 | $2.82 | Buy | $2.90 | Buy |
| MA 200 | $3.29 | Sell | $3.04 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 56.48 | Neutral |
| Stoch RSI (14) | 42.02 | Neutral |
| CCI (20) | 72.97 | Neutral |
| Williams %R (14) | -32.31 | Info |
| MACD (12,26,9) | 0.04 | Buy |
| ROC (12) | 10.87 | Buy |
| Bollinger %B (20,2) | 0.73 | Neutral |
| Stochastic %K (14) | 67.69 | Neutral |
| TRIX (15) | 0.40 | Buy |
| Awesome (5,34) | 0.34 | Buy |
| Ultimate (7,14,28) | 58.29 | Neutral |
| Momentum (10) | 0.44 | Buy |
| Aroon Osc (25) | 60.00 | Buy |
| Hull MA (9) | 3.13 | Sell |
| ADX (14) | 17.80 | Neutral |
| ATR (14) | 0.11 | Info |
The 30-day technical picture and momentum tilt toward bullish sentiment. RSI14 sits at 70, reinforcing upside potential alongside the SMA50 of $2.79 and SMA200 of $3.30. Watch the critical levels: support at $2.35 and resistance at $3.14. The 30-day range shows a low of $2.46 and a high of $4.01, outlining near-term volatility and potential breakout zones.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.35 | $3.06 | $3.61 | 0% | Neutral | |
| $2.87 | $3.75 | $5.22 | +22% | Bullish | |
| $3.53 | $4.78 | $7.00 | +56% | Bullish | |
| $3.88 | $5.45 | $8.27 | +78% | Bullish | |
| $4.32 | $6.25 | $9.80 | +104% | Bullish | |
| $4.03 | $5.99 | $9.65 | +96% | Bullish | |
| $4.23 | $6.45 | $10.65 | +111% | Bullish | |
| $4.63 | $7.25 | $12.23 | +137% | Bullish | |
| $4.65 | $7.45 | $12.83 | +143% | Bullish | |
| $6.13 | $10.04 | $17.60 | +228% | Bullish | |
| $6.81 | $12.40 | $23.48 | +305% | Bullish | |
| $12.73 | $28.13 | $59.48 | +819% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $2.35 | $3.06 | $3.62 | +0.00% |
| August 2026 | $2.44 | $2.91 | $3.59 | -4.93% |
| September 2026 | $2.48 | $2.99 | $3.74 | +2.63% |
| October 2026 | $2.46 | $2.99 | $3.79 | +0.24% |
| November 2026 | $2.31 | $2.82 | $3.61 | -5.72% |
| December 2026 | $2.27 | $2.79 | $3.61 | -0.97% |
Click any year to see its month-by-month ANIX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, ANIX is projected to trade between $2.35 and $3.61, averaging $3.06 — a potential gain of 0% from today's $3.06. A consolidation phase looks the most probable path here.
Anixa Biosciences, Inc.'s 2027 outlook centres on $3.75, within a $2.87 to $5.22 range. That is up +22% on the projected 2026 average. That marks a +22% change versus current levels. Momentum favours further upside here.
By 2028, ANIX could reach as high as $7.00, with a base case around $4.78 and support toward $3.53 — roughly +56% from $3.06. Buyers look set to stay in control over this stretch.
Expect ANIX to range from $3.88 to $8.27 through 2029. The $5.45 average target implies a +78% move from current prices. That is up +14% on the projected 2028 average. Momentum favours further upside here.
The ANIX price prediction for 2030 points to an average of $6.25 (low $4.32, high $9.80) — a potential gain of +104% on today's $3.06. Buyers look set to stay in control over this stretch.
In 2031, ANIX is projected to trade between $4.03 and $9.65, averaging $5.99 — a potential gain of +96% from today's $3.06. That is -4% versus the projected 2030 average. Momentum favours further upside here.
Anixa Biosciences, Inc.'s 2032 outlook centres on $6.45, within a $4.23 to $10.65 range. That is up +8% on the projected 2031 average. That marks a +111% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, ANIX could reach as high as $12.23, with a base case around $7.25 and support toward $4.63 — roughly +137% from $3.06. Momentum favours further upside here.
Expect ANIX to range from $4.65 to $12.83 through 2034. The $7.45 average target implies a +143% move from current prices. That is up +3% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The ANIX price prediction for 2035 points to an average of $10.04 (low $6.13, high $17.60) — a potential gain of +228% on today's $3.06. Momentum favours further upside here.
In 2040, ANIX is projected to trade between $6.81 and $23.48, averaging $12.40 — a potential gain of +305% from today's $3.06. That is up +24% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Anixa Biosciences, Inc.'s 2050 outlook centres on $28.13, within a $12.73 to $59.48 range. That is up +127% on the projected 2040 average. That marks a +819% change versus current levels. Momentum favours further upside here.
Investing $1,000 in ANIX today (≈ 326.797386 ANIX) could be worth
$9,194.34
+$8,194.34 (+819%) by 2050 · US Dollar
Based on the average projected ANIX price of $28.13 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ANIXwould be worth at today's price.
$1,000 invested in ANIX on Jul 10, 2025 (≈ 318.471327 ANIX) would be worth
$974.52
-$25.48 (-2.5%) today · 0.97× · US Dollar
Based on a ANIX entry price of $3.14 vs. today's $3.06.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.27 | $935.78 | -6.4% |
| 1 month ago | $2.35 | $1,302.13 | +30.2% |
| 3 months ago | $2.69 | $1,137.55 | +13.8% |
| 6 months ago | $3.16 | $968.35 | -3.2% |
| 1 year ago | $3.14 | $974.52 | -2.5% |
| All time (5.0y) ago | $3.69 | $829.27 | -17.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ANIX forecast.
Our base-case forecast reaches $6.10 around 2030.
Implied market cap at $6.10: $207.54M
The multi-year forecast shows an upward trajectory with the following implied paths. For 2026, the min is $2.35, the avg is $3.14, the max is $3.80, with ROI 0 and sentiment Neutral. In 2027, the avg rises to $3.94 (min $3.03, max $5.48) and ROI is 25.4% with Bullish sentiment.
By 2028, the avg is $5.02 (min $3.71, max $7.33) and ROI 59.9% (Bullish). In 2029, the avg is $5.77 (min $4.12, max $8.73) with ROI 83.6% (Bullish). The 2030 forecast shows an avg of $6.58 (min $4.57, max $10.27) and ROI 109.5% (Bullish).
The path extends through 2031–2050 with continued gains: 2031 avg $6.34 (min $4.29, max $10.16), ROI 101.9%; 2032 avg $6.97 (min $4.59, max $11.45), ROI 122%; 2033 avg $7.77 (min $5.00, max $13.04), ROI 147.6%; 2034 avg $8.04 (min $5.05, max $13.75), ROI 156%; 2035 avg $11.04 (min $6.79, max $19.24), ROI 251.5%. Looking further, 2040 avg is $13.48 (min $7.48, max $25.35), ROI 329.4%, and 2050 avg $31.42 (min $14.47, max $65.86), ROI 900.7%. These are estimates, not guarantees, and reflect bullish sentiment across many years while recognizing uncertainty and risk in future performance.
Tap a question to reveal the answer.
2030 min $4.57, avg $6.58, max $10.27, ROI 109.5%, sentiment BULLISH.
The long-term forecast shows bullish sentiment in multiple years with rising averages (e.g., 2027 avg $3.94, 2028 $5.02, 2029 $5.77, 2030 $6.58) and substantial ROIs (up to 109.5% by 2030 and 900.7% by 2050). These are estimates and not guarantees.
Yes. The current price is $3.14, and the 2026 forecast lists an average of $3.14. The 30-day range includes a high of $4.01.
The forecast shows a 2030 max of $10.27, with higher potential in later years: 2032 max $11.45, 2033 max $13.04, 2034 max $13.75, 2035 max $19.24, 2040 max $25.35, and 2050 max $65.86.
Current price $3.14; market cap $106.83M.
Anixa Biosciences, Inc. Community Discussion
0Share your Anixa Biosciences, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.